163 related articles for article (PubMed ID: 16299794)
1. Predictive markers for postsurgical recurrence of hepatocellular carcinoma.
Gao ZH
J Surg Oncol; 2005 Dec; 92(4):274-5. PubMed ID: 16299794
[No Abstract] [Full Text] [Related]
2. Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy.
Tanaka S; Arii S; Yasen M; Mogushi K; Su NT; Zhao C; Imoto I; Eishi Y; Inazawa J; Miki Y; Tanaka H
Br J Surg; 2008 May; 95(5):611-9. PubMed ID: 18311747
[TBL] [Abstract][Full Text] [Related]
3. [Liver transplantation for hepatocellular carcinoma].
Tanaka A; Tanaka K; Kaihara S; Ueda M; Uemoto S; Kiuchi T; Egawa H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():705-16. PubMed ID: 11762042
[No Abstract] [Full Text] [Related]
4. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
[TBL] [Abstract][Full Text] [Related]
5. Loss of E-cadherin mRNA and gain of osteopontin mRNA are useful markers for detecting early recurrence of HCV-related hepatocellular carcinoma.
Iso Y; Sawada T; Okada T; Kubota K
J Surg Oncol; 2005 Dec; 92(4):304-11. PubMed ID: 16299806
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody.
Tanaka K; Shimada H; Matsuo K; Nagano Y; Endo I; Togo S
Ann Surg Oncol; 2007 Mar; 14(3):1170-81. PubMed ID: 17195904
[TBL] [Abstract][Full Text] [Related]
7. Molecular markers and hepatocellular carcinoma: lending a helping hand in liver transplantation?
Dai Z; Yu L; Zhou J; Qiu SJ; Fan J
Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):211-3. PubMed ID: 19485802
[No Abstract] [Full Text] [Related]
8. [Surgical therapy of hepatic fibrolamellar carcinoma].
Meriggi F; Forni E
Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
[TBL] [Abstract][Full Text] [Related]
9. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
Kaido T; Takada Y; Uemoto S
Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
[No Abstract] [Full Text] [Related]
10. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and therapy of hepatocellular cancer].
Polterauer P; Knoflach P; Funovics J; Klicpera M; Aiginger P
Acta Med Austriaca Suppl; 1979; 6():316-8. PubMed ID: 233521
[TBL] [Abstract][Full Text] [Related]
12. A marker for predictions of HCC recurrence postresection?
Blendis L; Wong F
Gastroenterology; 2002 Dec; 123(6):2152-3. PubMed ID: 12454875
[No Abstract] [Full Text] [Related]
13. [Overview of percutaneous ablation therapy].
Ishikawa T; Teratani T; Tateishi R; Shiina S; Omata M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():494-500. PubMed ID: 11762000
[No Abstract] [Full Text] [Related]
14. Imaging of hepatocellular carcinoma recurrence post liver resection: a pictorial essay.
Kitzing B; Kitzing YX
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):337-44. PubMed ID: 23721143
[TBL] [Abstract][Full Text] [Related]
15. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
16. A three-gene predictor for early intrahepatic recurrence of hepatocellular carcinoma after curative hepatectomy.
Somura H; Iizuka N; Tamesa T; Sakamoto K; Hamaguchi T; Tsunedomi R; Yamada-Okabe H; Sawamura M; Eramoto M; Miyamoto T; Hamamoto Y; Oka M
Oncol Rep; 2008 Feb; 19(2):489-95. PubMed ID: 18202799
[TBL] [Abstract][Full Text] [Related]
17. [Serum arginase activity in patients with liver cirrhosis and hepatocellular carcinoma].
Chrzanowska A; Mielczarek-Puta M; Skwarek A; Krawczyk M; Barańczyk-Kuźma A
Wiad Lek; 2007; 60(5-6):215-8. PubMed ID: 17966882
[TBL] [Abstract][Full Text] [Related]
18. Neural cadherin overexpression is a predictive marker for early postoperative recurrence in hepatocellular carcinoma patients.
Seo DD; Lee HC; Kim HJ; Min HJ; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ; Yu E; Chun SY
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1112-8. PubMed ID: 17944884
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.
Ibrahim S; Roychowdhury A; Hean TK
Am J Surg; 2007 Jul; 194(1):17-22. PubMed ID: 17560903
[TBL] [Abstract][Full Text] [Related]
20. Epithelial to mesenchymal transition expression profiles as predictive biomarkers of recurrence following resection of HCC: implications for current clinical use and future stratification for systemic therapy.
Yopp AC; Singal AG
Ann Surg Oncol; 2014 Nov; 21(12):3723-4. PubMed ID: 25074660
[No Abstract] [Full Text] [Related]
[Next] [New Search]
